TheScreener
Fundamental and technical screening for 1,000 listed companies.
Use ⌘K to search stocks, screens, and features instantly.
Fundamental and technical screening for 1,000 listed companies.
Use ⌘K to search stocks, screens, and features instantly.
Comprehensive valuation analysis, historical median multiples, earnings yield, and sector peer benchmarking.
Torrent Pharmaceuticals Ltd. trades at 79.00x P/E compared to its estimated 3-year median of 75.05x. This represents a 5.3% premium to its multi-year historical trading baseline.
Compared to the wider Healthcare peer group median of 24.50x, TORNTPHARM is trading at a 222.4% premium.
| Company | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|
| ★ Torrent Pharmaceuticals Ltd.Active | 79.00 | 20.38 | 0.019 |
| Sun Pharmaceutical Industries Ltd.(SUNPHARMA) | 41.52 | 5.51 | 0.046 |
| Apollo Hospitals Enterprise Ltd.(APOLLOHOSP) | 65.49 | 13.41 | 0.013 |
| Zydus Lifesciences Ltd.(ZYDUSLIFE) | 23.78 | 4.42 | 0.012 |
| Cipla Ltd.(CIPLA) | 29.66 | 3.34 | 0.011 |
| Laurus Labs Ltd.(LAURUSLABS) | 117.32 | 19.65 | 0.01 |
Torrent Pharmaceuticals Ltd. (TORNTPHARM) currently trades at a Price-to-Earnings (P/E) multiple of 79.00 based on its latest reported trailing-twelve-month (TTM) earnings.
Torrent Pharmaceuticals Ltd.'s current P/E of 79.00 compares to its 3-year median P/E of 75.05 (+5.3% premium) and 5-year median P/E of 71.10.
Torrent Pharmaceuticals Ltd. operates in the Healthcare sector, where the sector median P/E is 24.50. At 79.00x, TORNTPHARM trades at a 222.4% premium to sector peers.
Torrent Pharmaceuticals Ltd. offers an Earnings Yield (E/P) of 1.26% and a PEG Ratio (Price/Earnings to Growth) of 3.66, reflecting the valuation relative to estimated EPS expansion trajectory.
For informational and educational purposes only. Not investment advice. Data may be delayed or incomplete. Consult a SEBI-registered investment adviser before making investment decisions.